Aurinia (AUPH) COO receives 116,144 PSUs and 70,230 stock options

Rhea-AI Filing Summary

Aurinia Pharmaceuticals Inc. reported that Chief Operating Officer Ryan Cole received new equity awards. He was granted 116,144 performance stock units, each representing a contingent right to receive one common share, with vesting tied to share-price targets and time-based conditions. He also received an option grant for 70,230 shares of common stock at an exercise price of $15.28 per share, expiring in 2036. These awards are compensation-related grants, and no open-market share purchases or sales were reported in this filing.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cole Ryan

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	70,230	$0.00	--
Grant/Award	Common Stock	116,144	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 70,230 shares (Direct, null); Common Stock — 116,144 shares (Direct, null)

Footnotes (1)

1. Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date. 33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.

Key Figures

Performance stock units granted: 116,144 units PSU price-based tranche: 46,820 units Time and price-based PSUs: 69,324 units +5 more

8 metrics

Performance stock units granted 116,144 units PSU grant to COO Ryan Cole tied to common shares

PSU price-based tranche 46,820 units Vest in four tranches upon achieving target share prices

Time and price-based PSUs 69,324 units Vest in two tranches at three- and five-year anniversaries

Stock options granted 70,230 options Employee stock options on Aurinia common stock

Option exercise price $15.28/share Conversion or exercise price for 70,230 options

Option expiration May 18, 2036 Expiration date of employee stock options

Shares following PSU grant 116,144 shares Total non-derivative units following grant entry

Options following grant 70,230 options Total derivative options position following grant

Key Terms

performance stock unit ("PSU"), target prices, retention periods, employee stock option (right to buy), +1 more

5 terms

performance stock unit ("PSU") financial

"Each performance stock unit ("PSU") represents a contingent right to receive one common share"

target prices financial

"common shares achieving four progressively higher target prices, with respective one year retention periods"

retention periods financial

"four progressively higher target prices, with respective one year retention periods per tranche achievement"

employee stock option (right to buy) financial

"Employee Stock Option (right to buy) with an exercise price of 15.2800"

vesting financial

"33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cole Ryan

(Last) (First) (Middle)

#140, 14315 - 118 AVENUE

(Street)

EDMONTON T5L 4S6

(City) (State) (Zip)

ALBERTA, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aurinia Pharmaceuticals Inc. [ AUPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		A		116,144(1)	A	$0	116,144	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$15.28	05/18/2026		A		70,230		(2)	05/18/2036	Common Stock	70,230	$0	70,230	D

Explanation of Responses:

1. Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date.

2. 33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.

Remarks:

	/s/ Ryan Cole	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Aurinia (AUPH) COO Ryan Cole receive in this Form 4?

Ryan Cole received 116,144 performance stock units and an employee stock option grant for 70,230 shares of Aurinia common stock at a $15.28 exercise price, expiring in 2036. Both transactions are equity compensation grants, not market trades.

How do the 116,144 performance stock units for Aurinia (AUPH) COO vest?

The 116,144 PSUs vest based on share-price and time targets. 46,820 PSUs vest in four price-based tranches with one-year retention periods, while 69,324 PSUs vest in two tranches at the three- and five-year anniversaries if significant share-price targets are achieved before vesting.

What are the terms of the 70,230 stock options granted to Aurinia (AUPH) COO?

Ryan Cole received 70,230 employee stock options with a $15.28 exercise price, expiring on May 18, 2036. According to the footnote, 33% vest one year after grant, and the remaining 67% vest in equal monthly installments over the following two years.

Did Aurinia (AUPH) COO Ryan Cole buy or sell any shares on the market?

No open-market purchases or sales are reported. The Form 4 shows grant or award acquisitions of PSUs and stock options with a $0.00 transaction price per share. These are compensation-related awards rather than discretionary market trades by the COO.

How many Aurinia (AUPH) PSUs and options does the COO hold after these grants?

Following these awards, Ryan Cole is shown holding 116,144 performance-based units tied to common shares and 70,230 employee stock options. The PSUs vest on share-price and time conditions, while the options vest over three years and are exercisable at $15.28 per share.